NCT03754062View on ClinicalTrials.gov

Pharmacological Modulation of Belief Salience

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions

HaloperidolPlaceboL-DOPA

Interventions

DRUG

Placebo - Cap

Administration of Placebo by pill.

DRUG

L-dopa

Administration of L-dopa by pill.

DRUG

Haloperidol

Administration of Haloperidol by pill.

Trial Locations (1)

W1T 7NF

Centre for Neuroimaging Sciences, London

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

lead

King's College London

OTHER